Measuring Cardiovascular Performance and Blood Flow Using Common But Never Compared Methods.

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

657 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-08-05

Study Completion Date

2022-01-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Measuring Cardiovascular Performance Using Common Methods in subjects.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Accuracy Study of a Non-Invasive Blood Pressure Cuff in Comparison to an Invasive Radial Arterial Blood Pressure

NCT01485120

Blood Pressure

COMPLETED NA

In-human Validation of a Technique for Measuring Central Aortic Hemodynamics With Peripheral Arterial Waveforms

NCT01567748

Coronary Artery Disease

COMPLETED

Association of Synchronous Four-limb blOod pRessure and Pulse Wave velocIty With Cardiovascular Events

NCT03521739

Blood Pressure Pulse Wave Analysis Ankle Brachial Index +1 more

UNKNOWN

Evaluation of a Non-Invasive Electrocardiogram-Assisted Blood Pressure Monitor

NCT02053623

Hypertension Atrial Fibrillation Obesity +2 more

TERMINATED

Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices

NCT04835857

Hypertension Healthy

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will conduct measurements of cardiovascular performance by echocardiography (Echo), Brain Natriuretic Peptide (BNP) blood serum levels and blood flow by volume plethysmography (VP) in subjects who meet the AHA/ACC criteria for screening for peripheral arterial disease (PAD).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

D012039 D001775

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

All subjects enrolled

The feasibility of conducting all three tests, echocardiography (Echo), Brain Natriuretic Peptide (BNP) and volume plethysmography (VP), on all subjects met the enrollment criteria.

No intervention

Intervention Type DIAGNOSTIC_TEST

No intervention

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* At least 50 Patients from New York Heart Association (NYHA) Class 1 (One or more AHA Risk Factors, asymptomatic), ≤75% (36) Male, ≥25% (12) Female
* At least 50 Patients from NYHA Class 2 (symptomatic), ≤75% (36) Male, ≥25% (12) Female

Exclusion Criteria

* Subjects on mechanical ventilation.
* Subjects who require decisions by a medical power of attorney.
* Subjects unable to safely perform forced expiration.
* Subjects with known technically difficult (TDS) trans-thoracic echocardiographic windows.

Minimum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No